Companies

TENET HEALTHCARE CORP

THC · CIK 0000070318 · operating

$235.43-1.65%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$20.66B
P/E15.18
Fwd P/E13.43
PEG
P/S0.97
P/B4.84
EV/EBITDA8.01
EV/Rev1.74

Profitability

Gross Margin
Op. Margin16.46%
Net Margin11.11%
ROE56.09%
ROA7.98%
FCF Margin11.87%

Financial Health

Current Ratio1.76
Debt/Equity4.91
Free Cash Flow$2.53B
Div. Yield

Growth & Other

Revenue Growth3.12%
EPS Growth-52.63%
Beta1.44
52W High$240.83
52W Low$109.82

About TENET HEALTHCARE CORP

Tenet Healthcare operates a diversified network of acute care hospitals, specialty facilities, and ambulatory care services across the United States. The company's core offerings include general medical and surgical hospital services such as intensive care, cardiothoracic surgery, neurosurgery, orthopedics, and trauma care. Beyond traditional hospital operations, Tenet provides specialized services including pediatric quaternary care with transplant programs, minimally invasive cardiac procedures, and stroke intervention services. The company also operates imaging centers, urgent care facilities, off-campus emergency departments, micro-hospitals, ambulatory surgery centers, and surgical hospitals.

The business is organized into two primary segments: Hospital Operations and Services, and Ambulatory Care. The Hospital Operations segment encompasses acute care and specialty hospitals offering comprehensive inpatient and outpatient services. The Ambulatory Care segment includes stand-alone facilities such as ambulatory surgery centers and urgent care centers that serve less acute patient needs.

Tenet operates a substantial healthcare footprint with approximately 77,000 full-time employees and is headquartered in Dallas, Texas. The company was founded in 1967 and maintains a national presence through its hospital network and outpatient facilities, positioning it as one of the larger operators of general hospitals in the United States.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$15.49$15.61-52.6%
2024$32.70$33.02+472.7%
2023$5.71$6.01+50.7%
2022$3.79$3.84-55.0%
2021$8.42$8.55+118.1%
2020$3.86$3.92+19200.0%
2019$0.02$0.02+150.0%
2018$-0.04$-0.04+99.4%
2017$-7.00$-7.00-262.7%
2016$-1.93$-1.93-36.9%
2015$-1.41$-1.41-1275.0%
2014$0.12$0.12+109.1%
2013$-1.32$-1.32-201.5%
2012$1.30$1.35+983.3%
2011$0.12$0.12-94.1%
2010$2.04$2.31

Annual Reports (10-K) · 12 filings

Report DateFiledAccession Number
2025-12-312026-02-170000070318-26-000012SEC ↗
2024-12-312025-02-180000070318-25-000009SEC ↗
2023-12-312024-02-160000070318-24-000016SEC ↗
2022-12-312023-02-210000070318-23-000010SEC ↗
2021-12-312022-02-180000070318-22-000013SEC ↗
2020-12-312021-02-190000070318-21-000008SEC ↗
2019-12-312020-02-240000070318-20-000014SEC ↗
2018-12-312019-02-250000070318-19-000017SEC ↗
2017-12-312018-02-260000070318-18-000011SEC ↗
2016-12-312017-02-270001558370-17-001079SEC ↗
2015-12-312016-02-220001558370-16-003350SEC ↗
2014-12-312015-02-230001558370-15-000132SEC ↗